<

 
Data updated 2025-04-25 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date10728558.7 (espacenet)  (Federated)  (European Patent Register), 20100628
Patent/reg. no. and dateDK/EP 2448933, 20130828
Publication date20120509
Priority no. and dateUS 221708 P, 20090630
EP pub. no. and date EP 2448933 20120509
Effective date
Applicant/ownerEli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.P81311273DK00E
InventorCHEN, Xinchao, Eli Liily And Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
FRANK, Scott, Alan, Eli Lilly And Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
REMICK, David, Michael, Eli Lilly And Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US,
PEDERSEN, Steven, Wayne, Eli Lilly And Company
Lilly Corporate Center
Indianapolis, Indiana 46285, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/55 (2006.01) , A61P 9/10 (2006.01) , C07D 403/12 (2006.01) 
TitleTrans-4-[[(5S)-5-[[[3,5-bis(trifluormethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexancarboxylsyre
Int. application no.US2010040125
Int. publication no.WO2011002696
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact